Executing clinical trials in complex glomerular diseases require moving beyond traditional functional involvement. As treatment paradigms and regulatory expectations for surrogate endpoints evolve, integrating medical oversight, Advanced Clinical Practitioners (ACPs) and Clinical Operations (ClinOps) from early startup through study closeout is critical to trial success. This webinar explores how an integrated, cross-functional approach can support glomerular disease clinical trials from protocol design through study execution.
This webinar presents a practical cross-functional blueprint that bridges early sponsor engagement and protocol design with seamless execution at the site level, while maintaining optimized trial management and regulatory compliance. The featured speakers will explore how embedding nephrology-experienced ACPs alongside therapeutically aligned Medical Monitors and CTMs can help reduce protocol deviations, safeguard primary endpoints and accelerate trial delivery for transformative renal therapies.
Additionally, the discussion will examine how sponsors can leverage transferable experience across glomerular disease indications even when disease-specific precedent is limited, applying integrated clinical expertise to evolving endpoint considerations and complex trial procedures.
Register for this webinar to learn how cross-functional clinical expertise can strengthen the design and execution of glomerular disease clinical trials.
Advancing Glomerulonephritis Clinical Research
Glomerulonephritis encompasses a range of rare but serious kidney disorders, requiring specialized expertise to navigate the complexities of clinical research. Medpace has relevant and recent experience in a broad spectrum of glomerular diseases, including glomerulonephritis associated with ANCA vasculitis, IgA nephropathy, membranous nephropathy, alport syndrome, C3 glomerulonephritis and focal segmental glomerulosclerosis. This experience is further enhanced by our glomerulonephritis working group, a forum consisting of our cross functional leaders highlighting lessons-learned from past trials and creative problem-solving strategies contributing to a track record of success in GN drug development.
Our seasoned clinical operations staff bring specific knowledge in conducting renal disease trials with a deep understanding of complicated procedures such as effective collection and processing of 24hr urine samples which are commonly used for primary endpoint analyses in these populations. With a track record of managing phase I-IV studies, Medpace is Trusted by Biotech® to deliver high-quality data and drive breakthroughs in glomerulonephritis treatment.